Skip to content
Disclosery

Qube Research & Technologies Ltd: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Qube Research & Technologies Ltd on GSK, newest first. How the timeline and the estimate are built.

Qube Research & Technologies Ltd held 1,078,767 GSK shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,078,767 shares
    Change vs previous 13F +530,545 shares

    0.06% of the 13F portfolio, value $56,548,966.

    13F-HR 0001729829-26-000014 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 548,222 shares
    Change vs previous 13F +548,222 shares

    0.04% of the 13F portfolio, value $30,256,372.

    13F-HR 0001729829-26-000004 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-12-31
    13F 0 shares
    Change vs previous 13F -107,377 shares

    13F-HR 0001729829-25-000045 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2024-09-30
    13F 107,377 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $4,389,572.

    13F-HR 0001729829-24-000013 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).